OXEPILAX

This brand name is authorized in Poland.

Active ingredients

The drug OXEPILAX contains one active pharmaceutical ingredient (API):

`1`	Oxcarbazepine UNII `VZI5B1W380` - OXCARBAZEPINE
	The pharmacological activity of oxcarbazepine is primarily exerted through the metabolite (MHD). The mechanism of action of oxcarbazepine and MHD is thought to be mainly based on the blockade of voltage-sensitive sodium channels, thus resulting in stabilisation of hyperexcited neural membranes, inhibition of repetitive neuronal firing, and diminishment of propagation of synaptic impulses.
	Read more about Oxcarbazepine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N03AF02	Oxcarbazepine	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AF Carboxamide derivatives
Discover more medicines within N03AF02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
PL	Rejestru Produktów Leczniczych	100297178, 100297184

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.